News and Conferences

Joseph Araujo and Laura Lockwood will attend the Animal Health Corridor Summit 2026 in Kansas City, Missouri, USA between August 31 and September 1, 2026.

Daniel Hutcheson, PhD, Chief Scientific Officer, and Laura Lockwood, Business Development Manager, will attend Sierra Nights in San Carlos, California, USA on August 5, 2026.

Mark Duxon, PhD, Chief Executive Officer, John Huxter, PhD, Global Head of Rodent Electrophysiology & Data Science; and Denvor Oorloff, Associate Director, Business Development, will attend the Alzheimer's Association International Conference (AAIC 2026) between July 12–16 at the ExCeL Centre in London, United Kingdom. The team will be available at Booth #845 to discuss translational approaches to Alzheimer's disease and neurodegeneration research, including behavioural, biomarker, electrophysiology, and translational model platforms.

John Huxter, PhD, Global Head of Rodent Electrophysiology & Data Science, will attend the Federation of European Neuroscience Societies (FENS) Conference between July 6–10 in Barcelona, Spain. Researchers interested in translational neuroscience, electrophysiology, EEG, grant support, and cross-disciplinary research collaboration are invited to connect with John or the Transpharmation team during the event.

Parisa Moazen, PhD, Scientific Director and Head of Operant Platform, will attend the CINP 37th World Congress of Neuropsychopharmacology in Glasgow, UK between June 26-29, 2026. Dr. Parisa will present a poster on Dissecting Distinct Aspects of Compulsivity Using SIP and 5-CSRTT.

Joseph Araujo, Chief Corporate Development Officer and Co-Founder, will attend the Bio International Convention between June 22-24 in San Diego, California, USA.

Briana Renda, PhD, Scientific Director, Abuse Liability, will attend the Research Society on Alcohol General Meeting in San Antonio, TX, USA between June 20-24, 2026. Dr. Briana will present a poster on 5-MeO-DMT Selectively Attenuates Oral Ethanol Self-Administration in Male and Female Wistar Rats.

Briana Renda, PhD, Scientific Director, Abuse Liability, and Guy Higgins, PhD, Scientific Advisor, will attend CPDD in Portland, OR, USA between June 13-17, 2026. Dr. Briana will also present a late-breaking oral titled 5-MeO-DMT and Naltrexone Selectively Attenuate Oral Ethanol Self-administration in Male and Female Wistar Rats. Dr. Briana and Dr. Guy will present a workshop in collaboration with Altasciences titled Driving Without a Roadmap: Addressing Regulatory Gaps and Translational Opportunities in Assessing CNS Drug Impairment.

Joseph Araujo, Chief Corporate Development Officer and Co-Founder, will attend the American College of Veterinary Internal Medicine Forum between June 11-13 in Seattle, Washington, USA.

Joseph Araujo, Chief Corporate Development Officer and Co-Founder, will attend the Veterinary Behavior Symposium between June 9-10 in Seattle, Washington USA. Joseph will also present new findings on “oral administration of PRI-002 and its impact on cognitive performance and cerebrospinal fluid biomarkers in aged Beagle dogs”.